News

The S&P/ASX 200 Index (ASX: XJO) is climbing higher again today. At the time of writing, the index is 0.22% higher, and up 11 ...
With CSL Ltd (ASX: CSL) shares now down 21% since Monday, the ASX 200 biotech giant looks like a screaming bargain. Here’s ...
S&P/ASX 200 Financials Index (ASX: XFJ) shares outperformed every other market sector in FY25 and are holding firm at near ...
Ord Minnett has just lifted its 12-month price target on a S&P/ASX All Ords Index (ASX: XAO) defence share by 93%...but there ...
Penny stocks come with high risk, high reward profiles. This one has grown into a $2 billion market cap company. Can it ...
The $15 billion S&P/ASX 200 Index (ASX: XJO) stock is roaring higher today following some smashing results. Here’s what’s ...
James Hardie shares are in focus as the company reports softer Q1 numbers but upbeat guidance post-AZEK acquisition.
Shares in this ASX 200 industrials stock are dipping on Wednesday morning after the group revealed its FY25 results.
Morgans has revealed new ratings and price targets on two of the big four S&P/ASX 200 Index (ASX: XJO) bank shares.
Are CSL Ltd (ASX: CSL) shares a buy? Let's see what the team at Bell Potter is saying about this blue chip biotech ...
Magellan Financial Group saw profit and assets rise, with higher dividends in FY25 as diversification boosted results.
This ASX 200 stock was an earnings season winner. Let's see what results had investors in a frenzy on Tuesday.